mortality/aging
|
• 1 to 5 weeks after tamoxifen treatment
|
growth/size/body
|
• in tamoxifen-treated mice
|
renal/urinary system
|
• enhanced ferrous iron incorporation in the kidney of 2 of 4 tamoxifen-treated mice
|
|
• in one tamoxifen-treated mouse
|
liver/biliary system
|
• in two tamoxifen-treated mice
|
|
• diffuse in one tamoxifen-treated mouse
|
homeostasis/metabolism
|
• enhanced ferrous iron incorporation in the kidney of 2 of 4 tamoxifen-treated mice
|
hematopoietic system
| N |
• tamoxifen-treated mice exhibit normal bone marrow cellularity
|


Analysis Tools